Predictive Oncology Files 8-K
Ticker: AGPU · Form: 8-K · Filed: May 30, 2024 · CIK: 1446159
Sentiment: neutral
Topics: corporate-event, filing
Related Tickers: PRED
TL;DR
PRED filed an 8-K on May 28th, check for updates.
AI Summary
Predictive Oncology Inc. filed an 8-K on May 30, 2024, reporting an event that occurred on May 28, 2024. The filing is categorized under 'Other Events' and 'Financial Statements and Exhibits'. The company was formerly known as Skyline Medical Inc. and Precision Therapeutics Inc.
Why It Matters
This 8-K filing indicates a corporate event or update from Predictive Oncology Inc., requiring investors to review the details for potential impacts on the company's operations or financial standing.
Risk Assessment
Risk Level: low — This filing is a standard 8-K for 'Other Events' and does not appear to contain immediately concerning financial or operational news.
Key Players & Entities
- Predictive Oncology Inc. (company) — Registrant
- May 28, 2024 (date) — Earliest event reported
- May 30, 2024 (date) — Filing date
- Skyline Medical Inc. (company) — Former company name
- Precision Therapeutics Inc. (company) — Former company name
FAQ
What specific event is reported under 'Other Events' in this 8-K filing?
The provided text does not specify the exact 'Other Event' being reported, only that it is categorized as such.
When was the earliest event reported in this filing?
The earliest event reported was on May 28, 2024.
What is the filing date of this 8-K?
The filing date is May 30, 2024.
What were some of the former names of Predictive Oncology Inc.?
Predictive Oncology Inc. was formerly known as Skyline Medical Inc. and Precision Therapeutics Inc.
Under which sections of the 8-K is this filing categorized?
This filing is categorized under 'Other Events' and 'Financial Statements and Exhibits'.
Filing Stats: 409 words · 2 min read · ~1 pages · Grade level 10 · Accepted 2024-05-30 17:04:14
Key Financial Figures
- $0.01 — ange on which registered Common stock, $0.01 par value POAI Nasdaq Capital Market
Filing Documents
- f8k_053024.htm (8-K) — 15KB
- exh_991.htm (EX-99.1) — 9KB
- 0001171843-24-003176.txt ( ) — 222KB
- gnw-20190101.xsd (EX-101.SCH) — 3KB
- gnw-20190101_def.xml (EX-101.DEF) — 25KB
- gnw-20190101_lab.xml (EX-101.LAB) — 33KB
- gnw-20190101_pre.xml (EX-101.PRE) — 22KB
- f8k_053024_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On May 28, 2024, Predictive Oncology Inc. issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release dated May 28, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Predictive Oncology Inc. Date: May 30, 2024 By: /s/ Josh Blacher Josh Blacher Interim Chief Financial Officer